Biotechnology Stocks
| # | 最近7天 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1559 | LEGN Legend Biotech Corporation - American Depositary Shares | 18.71 USD | -2.14% | -3.16% | -7.47% | -41.49% | 3.46 B USD | ||
| 1573 | ACAD ACADIA Pharmaceuticals Inc. - Common Stock | 19.58 USD | -0.36% | -2.20% | -29.13% | -6.58% | 3.37 B USD | ||
| 1584 | CELC Celcuity Inc. - Common Stock | 67.87 USD | +3.18% | -9.66% | -23.20% | +38.12% | 3.32 B USD | ||
| 1598 | VKTX Viking Therapeutics, Inc. - Common Stock | 27.73 USD | -2.84% | -10.11% | -14.68% | -22.54% | 3.23 B USD | ||
| 1617 | TARS Tarsus Pharmaceuticals, Inc. - Common Stock | 72.22 USD | -1.89% | -4.77% | -16.32% | +9.32% | 3.17 B USD | ||
| 1640 | ARQT Arcutis Biotherapeutics, Inc. - Common stock | 24.49 USD | +1.32% | -3.96% | +3.68% | +18.14% | 3.08 B USD | ||
| 1646 | DYN Dyne Therapeutics, Inc. - Common Stock | 16.37 USD | +2.50% | +2.12% | -15.53% | -30.07% | 3.06 B USD | ||
| 1658 | RCUS Arcus Biosciences, Inc. Common Stock | 23.82 USD | -2.89% | -6.33% | -15.14% | +56.92% | 3.03 B USD | ||
| 1660 | AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 27.20 USD | -0.84% | -4.56% | -14.63% | +88.63% | 3.03 B USD | ||
| 1670 | DNLI Denali Therapeutics Inc. - Common Stock | 18.67 USD | -2.56% | -10.46% | -13.92% | +15.46% | 2.98 B USD | ||
| 1673 | ELVN Enliven Therapeutics, Inc. - Common Stock | 40.63 USD | -1.76% | -14.25% | -31.19% | +96.66% | 2.98 B USD | ||
| 1720 | ZLAB Zai Lab Limited - American Depositary Shares | 24.81 USD | -1.98% | +0.69% | -2.13% | -7.04% | 2.79 B USD | ||
| 1738 | PGEN Precigen, Inc. - Common Stock | 7.60 USD | +0.80% | -8.43% | +13.43% | +136.76% | 2.72 B USD | ||
| 1787 | NAMS NewAmsterdam Pharma Company N.V. - Ordinary Shares | 21.26 USD | -3.93% | -13.58% | -16.13% | -41.38% | 2.54 B USD | ||
| 1788 | BEAM Beam Therapeutics Inc. - Common Stock | 24.60 USD | -0.69% | -1.60% | -0.73% | -13.62% | 2.54 B USD | ||
| 1797 | LQDA Liquidia Corporation - Common Stock | 28.02 USD | +5.02% | +4.98% | -58.42% | +23.98% | 2.51 B USD | ||
| 1839 | IRON Disc Medicine, Inc. - Common Stock | 60.77 USD | -0.67% | -5.87% | -19.92% | -13.81% | 2.33 B USD | ||
| 1843 | ADMA ADMA Biologics Inc - Common Stock | 10.33 USD | +1.87% | +3.09% | +10.01% | -30.11% | 2.31 B USD | ||
| 1851 | HRMY Harmony Biosciences Holdings, Inc. - Common Stock | 39.60 USD | +0.66% | -0.45% | -5.74% | +28.16% | 2.31 B USD | ||
| 1852 | NRIX Nurix Therapeutics, Inc. - Common stock | 22.21 USD | -2.29% | -6.37% | -16.00% | +98.13% | 2.30 B USD |
新闻 Biotechnology Stocks
周四盘后交易时段中波动的12只医疗保健股票
摩根大通维持对 Halozyme Therapeutics 的中性评级,将目标价上调至 78 美元
Ginkgo Bioworks将为NSF X-Labs研究人员提供自主实验室访问,向15亿美元科学计划贡献云实验室时间和蛋白质测试服务;将为NSF X-Labs团队提供云实验室时间和远程访问;将为NSF X-Labs团队提供蛋白质测试服务
Tenax Therapeutics 暂时暂停 TNX-103 的 LEVEL-2 试验入组,以修订标准;请求与 FDA 会面
更正:Biodexa Pharmaceuticals 宣布 1 拆 8 反向 ADS 拆分,自 10 月 26 日起生效
Quantum-Si 在 Proteus 开发项目中展示了对 19 种氨基酸的检测;该公司目前正致力于将这一能力部署到一款开发中的测序试剂盒中,以便在集成式 Proteus 仪器上常规使用
Tevogen签署意向书,拟评估与HRK Healthcare的潜在交易;预计有望实现合计约1亿美元的年度收入
Gainers Biotechnology Stocks
GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |